Information Provided By:
Fly News Breaks for March 17, 2015
ASPX
Mar 17, 2015 | 07:38 EDT
William Blair raised its price target for Auspex Pharmaceuticals to $105 following the company's Q4 results and keeps an Outperform rating on the name. The firm calls the Q4 results a nonevent and says it remains a buyer of the stock into the midyear data for Austedo use in tardive dyskinesia.
News For ASPX From the Last 2 Days
There are no results for your query ASPX